Abstract:Background: Acute kidney injury (AKI) remains a major global public health concern due to its high morbidity and mortality. The progression from AKI to chronic kidney disease (CKD) makes it a scientific problem to be solved. However, it is with lack of effective treatments. Summary: Both innate and adaptive immune systems participate in the inflammatory process during AKI, and excessive or dysregulated immune responses play a pathogenic role in renal fibrosis, which is an important hallmark of CKD. Studies on the pathogenesis of AKI and CKD have clarified that renal injury induces the production of various chemokines by renal parenchyma cells or resident immune cells, which recruits multiple-subtype lymphocytes in circulation. Some infiltrated lymphocytes exacerbate injury by proinflammatory cytokine production, cytotoxicity, and interaction with renal resident cells, which constructs the inflammatory environment and induces further injury, even death of renal parenchyma cells. Others promote tissue repair by producing protective cytokines. In this review, we outline the diversity of these lymphocytes and their mechanisms to regulate the whole pathogenic stages of AKI and CKD; discuss the chronological responses and the plasticity of lymphocytes related to AKI and CKD progression; and introduce the potential therapies targeting lymphocytes of AKI and CKD, including the interventions of chemokines, cytokines, and lymphocyte frequency regulation in vivo , adaptive transfer of ex-expanded lymphocytes, and the treatments of gut microbiota or metabolite regulations based on gut-kidney axis. Key Message: In the process of AKI and CKD, T helper (Th) cells, innate, and innate-like lymphocytes exert mainly pathogenic roles, while double-negative T (DNT) cells and regulatory T cells (Tregs) are confirmed to be protective. Understanding the mechanisms by which lymphocytes mediate renal injury and renal fibrosis is necessary to promote the development of specific therapeutic strategies to protect from AKI and prevent the progression of CKD.

Renal tubule injury: a driving force toward chronic kidney disease

How Tubular Epithelial Cell Injury Contributes to Renal Fibrosis

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury

Targeted Proximal Tubule Injury Triggers Interstitial Fibrosis and Glomerulosclerosis

Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition

The Tubulointerstitial Pathophysiology of Progressive Kidney Disease

Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury

Hypoxia and Renal Tubulointerstitial Fibrosis.

Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury

Adverse effects of acute tubular injury on the glomerulus: contributing factors and mechanisms

Epithelial Cell TGFβ Signaling Induces Acute Tubular Injury and Interstitial Inflammation.

Renal fibrosis: New insights into the pathogenesis and therapeutics

Crosstalk between glomeruli and tubules

Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease

Tubular atrophy in the pathogenesis of chronic kidney disease progression

Lymphocytes: Versatile Participants in Acute Kidney Injury and Progression to Chronic Kidney Disease

Is the Proximal Tubule the Focus of Tubulointerstitial Fibrosis?

The Emerging Role Of Innate Immunity In Chronic Kidney Diseases

Single-Cell Analysis Provides New Insights into the Roles of Tertiary Lymphoid Structures and Immune Cell Infiltration in Kidney Injury and Chronic Kidney Disease

Mechanisms of injury and repair of acute kidney injury